Biotech/Biomedical
News Category

Regentis Biomaterials Advances GelrinC as Potential Knee Cartilage Repair Breakthrough
Regentis Biomaterials is advancing GelrinC, an off-the-shelf hydrogel implant that supports cartilage regeneration, with European approval and an FDA-...

ORGANA International Courts Retail Buyers at ECRM to Expand U.S. Distribution
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to move beyond online sales and s...

Med-X Advances Nature-Cide Pest Control Platform Ahead of Nasdaq Listing
Med-X is expanding its natural pest-control brand Nature-Cide and has secured OMRI certification, positioning itself for growth as it prepares for a p...

Telomir-Zn Shows Growth Inhibition in Human and Canine Osteosarcoma Models
Telomir Pharmaceuticals' Telomir-Zn inhibits osteosarcoma growth in human and canine cell lines, opening a potential dual veterinary-human development...

FDA Clearance Paves Way for Quantum BioPharma's Phase 2 Multiple Sclerosis Trial
Quantum BioPharma has received FDA clearance of its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial in multiple sclerosis ...

GeoVax and CEPI Partner to Independently Evaluate GEO-MVA in Phase 3 Trial, Aiming to Diversify Global Mpox Vaccine Supply
GeoVax's agreement with CEPI to use its Centralised Laboratory Network for independent testing of GEO-MVA could strengthen regulatory confidence and h...

Aortic Stiffness, Not Menopause, May Drive Midlife Pulse Pressure Rise in Women
New research from the Framingham Heart Study indicates that the midlife rise in pulse pressure in women begins about two decades before menopause, sug...

Dental Design Studios Expands Full Arch Implants and Emergency Care to Nine Phoenix Offices
Dental Design Studios has expanded its cosmetic, implant, and emergency dental services to nine locations across the Phoenix metro area, increasing ac...

Engineered Suppressor tRNAs Show Promise for Duchenne Muscular Dystrophy
Tevard Biosciences announced preclinical research demonstrating that engineered suppressor tRNAs can restore full-length dystrophin and improve muscle...

Translational Longevity: The Critical Bridge from Lab to Patient
The August Wellness Index Report emphasizes that translating longevity breakthroughs into clinical care is essential, with the Translational Longevity...

Creative Biolabs Expands Functionalized Lipid-Based Delivery System Development
Creative Biolabs has broadened its functionalized lipid-based delivery capabilities to help researchers overcome stability, targeting, and controlled ...

Dr. Thanapoom Boonipat Scholarship for Future Doctors Opens to Undergraduates Nationwide
The Dr. Thanapoom Boonipat Scholarship for Future Doctors offers a $1,000 award to undergraduate students pursuing medical careers, emphasizing the im...

LiverRight and Aegle Medical Solutions Partner to Expand Non-Invasive Liver Care Across the U.S.
LiverRight and Aegle Medical Solutions have formed a strategic partnership to improve access to non-invasive liver assessment, specialist interpretati...

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services to Advance Biomedical Discovery
Creative Biolabs has broadened its single-cell and single-nucleus RNA sequencing and multi-omics offerings to help researchers overcome complex sample...

Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
A comprehensive review reveals that the tumor microenvironment actively sculpts natural killer cells into distinct functional subsets, offering a new ...

Nanox Expands Latin American Footprint with Costa Rica Distribution Agreement for Nanox.ARC
Nanox's distribution agreement with SOLME RC for Costa Rica marks its third Latin American market this year, advancing its mission to expand access to...

Life Sciences Investor Forum Showcases Seven Companies Advancing Cancer, Fibrosis, and Antibiotic Therapies
The September 17 Life Sciences Virtual Investor Forum will feature seven companies presenting live on novel treatments across oncology, fibrosis, drug...

SS Innovations Brings Robotic Cardiac Surgery to Sri Lanka with SSi Mantra 3.0
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Mantra 3.0 system,...

SS Innovations Reports 79% Surge in Robotic Procedures, Eyes FDA and CE Mark Approvals
SS Innovations International announced a 79% increase in procedures using its SSi Mantra surgical robot and significant global expansion, positioning ...

GeoVax Appeals Nasdaq Delisting, Reaffirms Strategic Focus on Vaccine and Cancer Programs
GeoVax Labs appeals its Nasdaq delisting determination, staying suspension pending an October hearing, while reaffirming its commitment to advancing i...

American Heart Association PREVENT Equations Integrated into Epic EHR Platform, Expanding Access to Advanced Cardiovascular Risk Assessment
The American Heart Association's PREVENT equations are now embedded in Epic's electronic health record platform, making guideline-recommended cardiova...

BioCorRx Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory Board
BioCorRx Inc. has appointed Richard J. Baum, former Acting Director of the White House Office of National Drug Control Policy, to its Strategic Adviso...

Nightfood Holdings Advances Service Robotics as Businesses Prioritize Efficiency
Nightfood Holdings Inc. (NGTF), through its TechForce Robotics unit, is developing AI-powered service robots for hospitality, pharmaceutical, laborato...

Greenland Mines Completes Skaergaard Bulk-Sampling, Advances Sarfartoq Fieldwork
Greenland Mines has completed its Skaergaard bulk-sampling program and advanced fieldwork at Sarfartoq, marking significant progress in its dual-proje...

NWB Finland Oy to Showcase Sustainable Bag-in-Box Water at ECRM 2026
NWB Finland Oy will present AINA Natural Water in eco-friendly bag-in-box packaging at ECRM 2026, offering retailers a way to meet sustainability goal...

FingerMotion Strengthens Liquidity and Cuts Cash Burn by Nearly 30% Under New Management
FingerMotion Inc. reported improved liquidity and a nearly 30% reduction in monthly cash burn within the first 30 days under new management, signaling...

Regentis Biomaterials Advances GelrinC Pivotal Trial and European Commercialization in First Half 2026
Regentis Biomaterials reported first half 2026 results, highlighting progress in its Phase III GelrinC trial, a 400% yield increase in manufacturing, ...

Rising Uninsured Rates Threaten Healthcare Access for All Americans
As more Americans lose health insurance due to rising premiums and recent legislative changes, the growing number of uninsured could have widespread c...

Gold-Silver Ratio Remains Valuable Indicator for Silver Prices, Study Finds
A recent study highlighted in the Silver Institute's latest report suggests that the gold-to-silver ratio is still a useful indicator for assessing si...

Nanox Expands Latin American Footprint with Costa Rica Distribution Agreement
Nanox Imaging signs a distribution agreement for its Nanox.ARC system in Costa Rica, marking its third Latin American market this year and advancing i...

Quantum BioPharma's Lucid-MS Advances to Phase 2 Trial, Targeting Myelin Repair in Multiple Sclerosis
Quantum BioPharma's FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class myelin-protecting and rebuilding candidate, could transform ...

TransCode Therapeutics Appoints Interim CFO Following Retirement of Tom Fitzgerald
TransCode Therapeutics has named John Tattory as interim CFO following the retirement of Tom Fitzgerald, bringing extensive financial leadership to th...

Regentis Biomaterials Pursues Cartilage Regeneration with GelrinC as Alternative to Symptom Management
Regentis Biomaterials is advancing GelrinC, an off-the-shelf hydrogel implant designed to regenerate knee cartilage, as an FDA-authorized pivotal tria...

TNT Targets U.S. Retail Expansion at ECRM to Challenge Competitive Sports Nutrition Market
German sports nutrition brand TNT is attending the ECRM Vitamin, Weight Management & Sports Nutrition Session to build retail partnerships and acceler...

VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC® Clinical Development
VERAXA Biotech's appointment of Dr. Christoph Erkel as Chief Scientific Officer signals a strategic push to advance its conditionally active BiTAC® T-...

Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction
Earth Science Tech's vertically integrated healthcare platform has delivered substantial revenue growth and a strengthened balance sheet, positioning ...

SS Innovations Launches Sri Lanka’s First Robotic Cardiac Surgery Program, Signaling Global Expansion
SS Innovations International Inc. has launched Sri Lanka’s first robotic cardiac surgery program, highlighting the company’s growing global footprint ...

FDA Clearance of Quantum BioPharma's Lucid-MS Marks Historic First in Multiple Sclerosis Treatment
Quantum BioPharma receives FDA clearance to launch a phase 2 trial of Lucid-MS, the first drug designed to shield and rebuild myelin in multiple scler...

Quantum BioPharma's Lucid-MS Advances Toward Phase 2 Trial After FDA Clearance
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to proceed to a Phase 2 trial in multiple scler...

FDA Clears First-in-Class MS Drug for Phase 2 Trial, Targeting Myelin Repair
Quantum BioPharma's Lucid-MS becomes the first drug designed to protect and rebuild myelin to enter human testing for multiple sclerosis, potentially ...

SS Innovations Reports 79% Surge in SSi Mantra Procedures, Expands Global Footprint
SS Innovations International announced a 79% increase in cumulative procedures using its SSi Mantra surgical robot, along with a 42% growth in install...

Helus Pharma CEO to Speak at Morgan Stanley Healthcare Conference, Spotlighting Psychedelic-Inspired Depression and Anxiety Treatments
Helus Pharma CEO Michael Halstead's upcoming fireside chat at the Morgan Stanley Global Healthcare Conference highlights the company's late-stage deve...

Onco-Innovations CMO Highlights Dual Selectivity of PNKP Inhibitor ONC010 in BioMedWire Podcast
Onco-Innovations' CMO discusses the potential of ONC010, a novel PNKP inhibitor with dual selectivity mechanisms, as it advances toward first-in-human...

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial After FDA Clearance
Quantum BioPharma's FDA clearance of its IND application for Lucid-MS marks a critical step toward a Phase 2 trial in multiple sclerosis, potentially ...

American Fusion Advances Texatron Program into Active Testing Phase with 100,000 Atmospheres Milestone
American Fusion's Texatron program has entered active testing with record-high confinement pressures, signaling a critical step toward commercial fusi...

American Fusion's Texatron Enters Active Testing with 100,000 Atmospheres, Drawing Analyst Coverage
American Fusion's Texatron fusion program has moved into active testing, achieving record pressures and attracting new analyst coverage, signaling a c...


